ProstaLund AB (publ) (PLUN.ST)
SEK 0.22
(-3.86%)
SEK 0.22
(-3.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 31.95 Million SEK | 34.47% |
| 2022 | 23.76 Million SEK | 5.45% |
| 2021 | 22.53 Million SEK | 15.79% |
| 2020 | 19.46 Million SEK | 0.16% |
| 2019 | 19.43 Million SEK | -7.77% |
| 2018 | 21.07 Million SEK | -18.66% |
| 2017 | 25.9 Million SEK | 25.5% |
| 2016 | 20.64 Million SEK | 20.12% |
| 2015 | 17.18 Million SEK | 14.84% |
| 2014 | 14.96 Million SEK | 40.75% |
| 2013 | 10.63 Million SEK | 50.07% |
| 2012 | 7.08 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.43 Million SEK | -14.82% |
| 2024 Q2 | 9.34 Million SEK | 24.48% |
| 2023 Q3 | 9.76 Million SEK | 27.26% |
| 2023 FY | 31.95 Million SEK | 34.47% |
| 2023 Q1 | 6.97 Million SEK | -1.08% |
| 2023 Q2 | 7.67 Million SEK | 10.11% |
| 2023 Q4 | 8.72 Million SEK | -10.69% |
| 2022 Q2 | 6.09 Million SEK | 4.21% |
| 2022 Q3 | 4.77 Million SEK | -21.6% |
| 2022 Q4 | 7.04 Million SEK | 47.47% |
| 2022 Q1 | 5.84 Million SEK | -10.5% |
| 2022 FY | 23.76 Million SEK | 5.45% |
| 2021 FY | 22.53 Million SEK | 15.79% |
| 2021 Q1 | 5.55 Million SEK | -21.34% |
| 2021 Q3 | 4.74 Million SEK | -16.83% |
| 2021 Q2 | 5.7 Million SEK | 2.63% |
| 2021 Q4 | 6.53 Million SEK | 37.76% |
| 2020 FY | 19.46 Million SEK | 0.16% |
| 2020 Q1 | 4.86 Million SEK | -3.8% |
| 2020 Q2 | 3.87 Million SEK | -20.32% |
| 2020 Q4 | 7.06 Million SEK | 93.24% |
| 2020 Q3 | 3.65 Million SEK | -5.7% |
| 2019 FY | 19.43 Million SEK | -7.77% |
| 2019 Q2 | 5.13 Million SEK | 0.1% |
| 2019 Q1 | 5.12 Million SEK | -14.04% |
| 2019 Q4 | 5.05 Million SEK | 23.01% |
| 2019 Q3 | 4.11 Million SEK | -19.91% |
| 2018 Q1 | 5.79 Million SEK | -28.32% |
| 2018 Q4 | 5.96 Million SEK | 45.32% |
| 2018 Q3 | 4.1 Million SEK | -21.14% |
| 2018 FY | 21.07 Million SEK | -18.66% |
| 2018 Q2 | 5.2 Million SEK | -10.07% |
| 2017 Q4 | 8.07 Million SEK | 92.42% |
| 2017 FY | 25.9 Million SEK | 25.5% |
| 2017 Q3 | 4.19 Million SEK | -43.77% |
| 2017 Q2 | 7.46 Million SEK | 30.23% |
| 2017 Q1 | 5.73 Million SEK | -8.8% |
| 2016 FY | 20.64 Million SEK | 20.12% |
| 2016 Q3 | 4.18 Million SEK | -15.6% |
| 2016 Q4 | 6.28 Million SEK | 50.35% |
| 2016 Q1 | 5.22 Million SEK | 23.11% |
| 2016 Q2 | 4.95 Million SEK | -5.1% |
| 2015 FY | 17.18 Million SEK | 14.84% |
| 2015 Q4 | 4.24 Million SEK | 17.29% |
| 2015 Q3 | 3.61 Million SEK | -29.28% |
| 2015 Q2 | 5.11 Million SEK | 21.25% |
| 2015 Q1 | 4.21 Million SEK | 20.56% |
| 2014 Q2 | 3.76 Million SEK | 13.2% |
| 2014 Q1 | 3.32 Million SEK | -6.6% |
| 2014 FY | 14.96 Million SEK | 40.75% |
| 2014 Q4 | 3.49 Million SEK | -16.24% |
| 2014 Q3 | 4.17 Million SEK | 10.89% |
| 2013 Q2 | 2.53 Million SEK | 16.77% |
| 2013 Q1 | 2.17 Million SEK | -2.86% |
| 2013 Q3 | 2.36 Million SEK | -6.75% |
| 2013 Q4 | 3.56 Million SEK | 50.63% |
| 2013 FY | 10.63 Million SEK | 50.07% |
| 2012 FY | 7.08 Million SEK | 0.0% |
| 2012 Q3 | 1.61 Million SEK | 0.0% |
| 2012 Q4 | 2.23 Million SEK | 38.65% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ambea AB (publ) | 2.46 Billion SEK | 98.701% |
| Attendo AB (publ) | 4.64 Billion SEK | 99.312% |
| Humana AB (publ) | 376 Million SEK | 91.5% |